Acurx Pharmaceuticals, Inc. to Discuss 2022 First Quarter Financial Results on May 11, 2022 Conference Call and Provide Business Update
- Friday, April 29, 2022, 7:10
- PR Newswire
- Add a comment
STATEN ISLAND, N.Y., April 29, 2022 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will…
About the Author
admin has written 20022 stories on this site.